ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 124 filers reported holding ANIKA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,090,225 | +120101.2% | 58,525 | +167114.3% | 0.00% | – |
| Q2 2023 | $907 | -56.7% | 35 | -52.1% | 0.00% | – |
| Q1 2023 | $2,095 | +4.8% | 73 | +2.8% | 0.00% | – |
| Q4 2022 | $2,000 | -98.9% | 71 | -99.1% | 0.00% | – |
| Q3 2022 | $180,000 | +39.5% | 7,553 | +30.5% | 0.00% | – |
| Q2 2022 | $129,000 | +163.3% | 5,786 | +195.5% | 0.00% | – |
| Q1 2022 | $49,000 | -23.4% | 1,958 | +8.2% | 0.00% | – |
| Q4 2021 | $64,000 | -7.2% | 1,810 | +9.6% | 0.00% | – |
| Q3 2021 | $69,000 | +165.4% | 1,652 | +169.1% | 0.00% | – |
| Q2 2021 | $26,000 | +2500.0% | 614 | +1515.8% | 0.00% | – |
| Q1 2021 | $1,000 | -98.6% | 38 | -97.5% | 0.00% | – |
| Q4 2020 | $69,000 | +430.8% | 1,550 | +318.9% | 0.00% | – |
| Q3 2020 | $13,000 | 0.0% | 370 | +3.9% | 0.00% | – |
| Q2 2020 | $13,000 | -13.3% | 356 | -26.7% | 0.00% | – |
| Q1 2020 | $15,000 | – | 486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |